CBD News

This week’s biggest CBD news is that the members of the 2018 Farm Bill Conference Committee have reached an agreement. This means that they’ve resolved the differences

The day after Thanksgiving is the biggest shopping day of the year, and people around the US are preparing for the annual spectacle of Black Friday. That’s

A paper in this month’s edition of Forensic Science International took a close look at adulterated CBD e-liquid products. The researchers analyzed samples of nine products from a

With the resignation of Attorney General Jeff Sessions this week, hemp and medical cannabis advocates are hoping for a friendlier face to step into the role. Sessions

Epidiolex, the first cannabis-derived medicine that the FDA has ever approved, is now available in pharmacies in the United States. This follows the DEA’s limited rescheduling of

Can non-cannabis plants produce the compounds known as cannabinoids? Some researchers say yes. The latest contender for an alternate plant source of cannabinoids is liverwort.

Let’s start by getting this week’s biggest cannabis story out of the way: yes, Canada legalized it! And for our friends in the north, Bloomberg put together

The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD) will consider reclassifying cannabis when they meet in Geneva next month. And as part of this

In this week’s top CBD story, the FDA memo recommending that CBD be categorized as a Schedule V controlled substance was made public. And it contained a

In this week’s biggest CBD news development, the Drug Enforcement Agency has rescheduled FDA-approved drugs containing CBD: